| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.30(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,848 |
| 52
Week Range: |
$6.1 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
6,313 |
13,261 |
14,828 |
| Total Sell Value |
$0 |
$61,867 |
$119,170 |
$133,715 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
4 |
7 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Chai-Onn Robert Roswell |
EVP, CLO, General Counsel |
• – – |
2015-05-04 |
4 |
AS |
$222.54 |
$20,237,443 |
D/D |
(90,938) |
43,187 |
|
- |
|
| Chai-Onn Robert Roswell |
EVP, CLO, General Counsel |
• – – |
2015-05-04 |
4 |
OE |
$25.42 |
$2,311,644 |
D/D |
90,938 |
134,125 |
|
- |
|
| Stolz Brian M. |
EVP, Administration & CHCO |
• – – |
2015-05-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,921) |
94,139 |
|
- |
|
| Stolz Brian M. |
EVP, Administration & CHCO |
• – – |
2015-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,675 |
96,060 |
|
- |
|
| Kornwasser Laizer |
EVP, Company Group Chairman |
• – – |
2015-04-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,216) |
98,824 |
|
- |
|
| Schiller Howard Bradley |
Chief Financial Officer |
• – – |
2015-04-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,638) |
289,369 |
|
- |
|
| Schiller Howard Bradley |
Chief Financial Officer |
• – – |
2015-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,500 |
306,007 |
|
- |
|
| Mirovsky Pavel |
EVP, Pres. & GM Valeant EMENA |
• – – |
2015-04-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
36,675 |
|
- |
|
| Kornwasser Laizer |
EVP, Company Group Chairman |
• – – |
2015-04-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,337) |
100,040 |
|
- |
|
| Kornwasser Laizer |
EVP, Company Group Chairman |
• – – |
2015-04-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,000 |
123,377 |
|
- |
|
| Mirovsky Pavel |
President, EMENA |
• – – |
2015-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,175 |
34,175 |
|
- |
|
| Provencio Norma Ann |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
188 |
141,407 |
|
- |
|
| Melas Kyriazi Theo |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
132 |
220,039 |
|
- |
|
| Ingram Robert Alexander |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
122 |
66,775 |
|
- |
|
| Farmer Ronald Harold |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
132 |
33,319 |
|
- |
|
| Goggins Colleen A |
Director |
– • – |
2015-03-27 |
4 |
A |
$198.12 |
$99,062 |
D/D |
500 |
3,366 |
|
- |
|
| Chai-Onn Robert Roswell |
EVP, CLO, General Counsel |
• – – |
2015-03-03 |
4 |
OE |
$6.10 |
$133,029 |
D/D |
21,808 |
43,187 |
|
- |
|
| Chai-Onn Robert Roswell |
EVP, CLO, General Counsel |
• – – |
2015-03-02 |
4 |
AS |
$200.01 |
$18,189,091 |
D/D |
(90,939) |
21,379 |
|
- |
|
| Chai-Onn Robert Roswell |
EVP, CLO, General Counsel |
• – – |
2015-03-02 |
4 |
OE |
$25.42 |
$2,311,669 |
D/D |
90,939 |
112,296 |
|
- |
|
| Mirovsky Pavel |
EVP, Pres. & GM Valeant EMEA |
• – – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Pearson J. Michael |
Chief Executive Officer |
• – – |
2015-02-26 |
4 |
GA |
$0.00 |
$0 |
D/D |
86,641 |
2,812,063 |
|
- |
|
| Kellen Ari |
EVP, Company Group Chairman |
• – – |
2015-02-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,855) |
88,767 |
|
- |
|
| Kornwasser Laizer |
EVP, Company Group Chairman |
• – – |
2015-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(765) |
78,377 |
|
- |
|
| Stolz Brian M. |
EVP, Administration and CHCO |
• – – |
2015-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(760) |
92,385 |
|
- |
|
| Schiller Howard Bradley |
Chief Financial Officer |
• – – |
2015-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,607) |
283,507 |
|
- |
|
705 Records found
|
|
Page 26 of 29 |
|
|
0.04 (0.62%) 
